Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Journal of the American Chemical Society Year : 2007

Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.

Sophie Laurent
Charlotte Rivière

Abstract

Luminescent hybrid nanoparticles with a paramagnetic Gd2O3 core were applied as contrast agents for both in vivo fluorescence and magnetic resonance imaging. These hybrid particles were obtained by encapsulating Gd2O3 cores within a polysiloxane shell which carries organic fluorophores and carboxylated PEG covalently tethered to the inorganic network. Longitudinal proton relaxivities of these particles are higher than the positive contrast agents like Gd-DOTA which are commonly used for clinical magnetic resonance imaging. Moreover these particles can be followed up by fluorescence imaging. This study revealed that these particles suited for dual modality imaging freely circulate in the blood vessels without undesirable accumulation in lungs and liver.

Domains

Cancer Materials

Dates and versions

inserm-00313780 , version 1 (27-08-2008)

Identifiers

Cite

Jean-Luc Bridot, Anne-Charlotte Faure, Sophie Laurent, Charlotte Rivière, Claire Billotey, et al.. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.. Journal of the American Chemical Society, 2007, 129 (16), pp.5076-84. ⟨10.1021/ja068356j⟩. ⟨inserm-00313780⟩
363 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More